JP2023526248A5 - - Google Patents
Info
- Publication number
- JP2023526248A5 JP2023526248A5 JP2022568794A JP2022568794A JP2023526248A5 JP 2023526248 A5 JP2023526248 A5 JP 2023526248A5 JP 2022568794 A JP2022568794 A JP 2022568794A JP 2022568794 A JP2022568794 A JP 2022568794A JP 2023526248 A5 JP2023526248 A5 JP 2023526248A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- compound
- substituents independently
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024218934A JP7715911B2 (ja) | 2020-05-13 | 2024-12-13 | 神経筋疾患の処置のためのピリダジノン化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063024439P | 2020-05-13 | 2020-05-13 | |
| US63/024,439 | 2020-05-13 | ||
| PCT/US2021/031979 WO2021231565A1 (en) | 2020-05-13 | 2021-05-12 | Pyridazinone compounds for the treatment of neuromuscular diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218934A Division JP7715911B2 (ja) | 2020-05-13 | 2024-12-13 | 神経筋疾患の処置のためのピリダジノン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023526248A JP2023526248A (ja) | 2023-06-21 |
| JP2023526248A5 true JP2023526248A5 (https=) | 2024-05-22 |
| JP7606537B2 JP7606537B2 (ja) | 2024-12-25 |
Family
ID=76284178
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568794A Active JP7606537B2 (ja) | 2020-05-13 | 2021-05-12 | 神経筋疾患の処置のためのピリダジノン化合物 |
| JP2024218934A Active JP7715911B2 (ja) | 2020-05-13 | 2024-12-13 | 神経筋疾患の処置のためのピリダジノン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218934A Active JP7715911B2 (ja) | 2020-05-13 | 2024-12-13 | 神経筋疾患の処置のためのピリダジノン化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230159513A1 (https=) |
| EP (2) | EP4149620B1 (https=) |
| JP (2) | JP7606537B2 (https=) |
| WO (1) | WO2021231565A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2958954T3 (es) | 2018-11-06 | 2024-02-16 | Edgewise Therapeutics Inc | Compuestos de piridazinona y usos de los mismos |
| WO2020097258A1 (en) | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP3877052B1 (en) | 2018-11-06 | 2023-08-16 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP4433473A1 (en) * | 2021-11-17 | 2024-09-25 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP4509505A4 (en) * | 2022-04-15 | 2026-04-15 | Wuhan Humanwell Innovative Drug Res And Development Center Limited Company | KIF18A INHIBITOR AND ITS USAGE |
| EP4688756A1 (en) | 2023-03-27 | 2026-02-11 | Edgewise Therapeutics, Inc. | Quinazoline dione compounds and uses thereof |
| WO2024206339A1 (en) | 2023-03-27 | 2024-10-03 | Edgewise Therapeutics, Inc. | Quinolinone amide compounds and uses thereof |
| WO2025207622A1 (en) * | 2024-03-26 | 2025-10-02 | Edgewise Therapeutics, Inc. | Quinolinone, benzoxazinone, and quinoline compounds and uses thereof |
| WO2025207677A1 (en) * | 2024-03-26 | 2025-10-02 | Edgewise Therapeutics, Inc. | Quinazolinone compounds and uses thereof |
| WO2025207665A1 (en) * | 2024-03-26 | 2025-10-02 | Edgewise Therapeutics, Inc. | Quinolinone compounds and uses thereof |
| WO2025207679A1 (en) * | 2024-03-26 | 2025-10-02 | Edgewise Therapeutics, Inc. | Quinazoline dione compounds and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376667A (en) * | 1992-12-31 | 1994-12-27 | Entropin, Inc. | Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties |
| ES2293638T3 (es) | 1994-03-25 | 2008-03-16 | Isotechnika, Inc. | Mejora de la eficacia de farmacos por deuteracion. |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| AR081331A1 (es) * | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US8759380B2 (en) * | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
| WO2018081378A1 (en) * | 2016-10-26 | 2018-05-03 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods for modulating cftr |
| CN110573161A (zh) | 2017-03-28 | 2019-12-13 | 勃林格殷格翰国际有限公司 | 用于治疗肌营养不良的方法的尼达尼布 |
| US11065243B2 (en) * | 2017-10-27 | 2021-07-20 | Sonic Master Limited | Inhibitors of DUX4 induction for regulation of muscle function |
| ES2958954T3 (es) * | 2018-11-06 | 2024-02-16 | Edgewise Therapeutics Inc | Compuestos de piridazinona y usos de los mismos |
| WO2020097258A1 (en) * | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP3877052B1 (en) * | 2018-11-06 | 2023-08-16 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP4433473A1 (en) * | 2021-11-17 | 2024-09-25 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
-
2021
- 2021-05-12 EP EP21730365.0A patent/EP4149620B1/en active Active
- 2021-05-12 WO PCT/US2021/031979 patent/WO2021231565A1/en not_active Ceased
- 2021-05-12 EP EP24207354.2A patent/EP4473968A3/en active Pending
- 2021-05-12 JP JP2022568794A patent/JP7606537B2/ja active Active
-
2022
- 2022-11-07 US US18/053,318 patent/US20230159513A1/en active Pending
-
2024
- 2024-12-13 JP JP2024218934A patent/JP7715911B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023526248A5 (https=) | ||
| JP2022506686A5 (https=) | ||
| JP2024540485A5 (https=) | ||
| JP2023526247A5 (https=) | ||
| JP2020517707A5 (https=) | ||
| JP2022506685A5 (https=) | ||
| EP3224237B1 (en) | Necrosis inhibitors | |
| JP2019525899A5 (https=) | ||
| JP2018538248A5 (https=) | ||
| JP2014508128A5 (https=) | ||
| JP2021514400A5 (https=) | ||
| JP2021527126A5 (https=) | ||
| JP2016534134A5 (https=) | ||
| JP2009526830A5 (https=) | ||
| RU2008107733A (ru) | Ингибиторы gsk-3 | |
| JP2021534106A5 (https=) | ||
| JP2020520955A5 (https=) | ||
| JP2004521908A5 (https=) | ||
| JP2006513268A5 (ja) | アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体 | |
| JP2015523339A5 (https=) | ||
| JP2020531531A5 (https=) | ||
| JP2005525392A5 (https=) | ||
| RU2016120610A (ru) | Производное сульфонамида и его применение в медицине | |
| CA2433417A1 (en) | Novel 1,2-diphenylethene derivatives for treatment of immune diseases | |
| JP2019527724A5 (https=) |